Regulus Therapeutics Inc. (RGLS)
NASDAQ: RGLS
· Real-Time Price · USD
8.16
0.00 (0.00%)
At close: Jun 24, 2025, 3:59 PM
Regulus Therapeutics Ratios and Metrics
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
PE Ratio | -3.01 | -2.02 | -1.83 | -2.77 | -2.38 | -0.8 | -0.86 | -1 | -0.5 | -0.85 | -0.84 | -1.03 | -1.63 | -1.2 | -1.74 | -2.59 | -4.62 |
PEG Ratio | 0.12 | 0.42 | -0.08 | 0.07 | 0.09 | n/a | -0.11 | 0.08 | -0.1 | 0.04 | n/a | -0.12 | 0.05 | 0.04 | -0.06 | 0.36 | -0.02 |
PS Ratio | n/a | n/a | n/a | n/a | n/a | 85.71 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
PB Ratio | 1.68 | 1.35 | 1.18 | 1.25 | 0.75 | 1.22 | 0.95 | 0.83 | 0.54 | 0.69 | 0.64 | 0.71 | 0.89 | 0.62 | 2.07 | 1.70 | 4.10 |
P/FCF Ratio | -11.19 | -8.74 | -10.85 | -10.45 | -8.97 | -4.18 | -3.94 | -4.49 | -1.76 | -3.65 | -3.78 | -4.76 | -6.75 | -4.35 | -10.75 | -12.13 | -19.29 |
P/OCF Ratio | -10.91 | -8.74 | -10.88 | -10.53 | -9.21 | -4.23 | -4.28 | -4.49 | -1.76 | -3.69 | -3.78 | -4.91 | -6.86 | -4.37 | -10.8 | -12.44 | -19.47 |
OCF/S Ratio | n/a | n/a | n/a | n/a | n/a | -20.28 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Debt / Equity Ratio | 0.02 | 0.00 | 0.01 | 0.01 | 0.02 | 0.15 | 0.12 | 0.13 | 0.20 | 0.19 | 0.16 | 0.15 | 0.14 | 0.13 | 0.25 | 0.20 | 0.28 |
Quick Ratio | 16.31 | 10.98 | 14.14 | 17.86 | 16.79 | 2.96 | 4.25 | 4.65 | 3.57 | 3.78 | 4.69 | 8.82 | 11.67 | 11.90 | 3.23 | 4.31 | 3.36 |
Current Ratio | 16.31 | 10.98 | 14.14 | 18.46 | 17.32 | 2.96 | 4.25 | 5.03 | 3.92 | 3.78 | 4.69 | 8.82 | 12.32 | 12.48 | 3.49 | 4.65 | 3.70 |
Asset Turnover | n/a | n/a | n/a | n/a | n/a | 0.01 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Interest Coverage | 619.88 | -1.06K | -3.04K | -211.38 | -108.96 | -72.81 | -59.31 | -43.54 | -39.83 | -35.37 | -43.22 | -44.29 | -42.38 | -32.52 | -40.09 | -30.73 | -26.84 |
Return on Equity | -0.14 | -0.17 | -0.16 | -0.11 | -0.08 | -0.38 | -0.28 | -0.21 | -0.27 | -0.2 | -0.19 | -0.17 | -0.14 | -0.13 | -0.3 | -0.16 | -0.22 |
Return on Assets | -0.13 | -0.15 | -0.15 | -0.11 | -0.07 | -0.26 | -0.21 | -0.16 | -0.19 | -0.15 | -0.14 | -0.14 | -0.11 | -0.1 | -0.2 | -0.12 | -0.15 |
Return on Invested Capital | -0.15 | -0.18 | -0.17 | -0.12 | -0.08 | -0.35 | -0.26 | -0.19 | -0.23 | -0.18 | -0.16 | -0.14 | -0.12 | -0.11 | -0.23 | -0.15 | -0.17 |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | n/a | n/a | n/a | n/a | n/a | 0.75 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Net Profit Margin | n/a | n/a | n/a | n/a | n/a | -26.69 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Profit Margin | n/a | n/a | n/a | n/a | n/a | -26.69 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Profit Margin | n/a | n/a | n/a | n/a | n/a | -27.48 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
EBITDA Margin | n/a | n/a | n/a | n/a | n/a | -26.06 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |